Medpace (MEDP) Director Fred B. Davenport Jr. Exercises Options, Sells Shares

What Happened

• Fred B. Davenport Jr., a director of Medpace Holdings, exercised stock options on Aug 19, 2026 and then sold most of the resulting shares. He exercised three option tranches totalling 7,583 shares (1,903 @ $133.87; 3,858 @ $84.36; 1,822 @ $164.68) and realized the stated exercise costs shown. He sold 7,283 shares in open-market trades at a weighted average price of $606.15, generating proceeds of approximately $4,414,590.

Key Details

• Transaction date: 2026-08-19 (Form 4 filed 2026-08-21 — appears timely).
• Exercise (acquisitions): 1,903 shares @ $133.87 ($254,755); 3,858 @ $84.36 ($325,461); 1,822 @ $164.68 ($300,047).
• Sale: 7,283 shares sold in open market at weighted avg $606.15; proceeds ~$4,414,590. (Footnote: sale prices ranged $605.59–$607.202; weighted avg reported.)
• Derivative reporting: the filing also shows the related option instruments disposed at $0, consistent with exercise of those options.
• Net retained from these transactions: 300 shares (7,583 exercised − 7,283 sold). The Form 4 does not disclose total shares beneficially owned after the transaction.
• Footnotes: some shares/options are owned by a trust for his benefit (F2). Vesting dates: the three option grants vested in full on 05/18/2023, 05/13/2021, and 05/14/2022 (F3–F5).

Context

• This is a common pattern: the director exercised vested options and sold most of the acquired shares (effectively a sell following exercise). The derivative entries and zero-dollar disposals reflect surrender/ending of the option instruments upon exercise. The filing is factual and does not state motivations; proceeds were about $4.41M and the sales occurred across multiple trades at about $605.59–$607.20 per share.